AstraZeneca, a multinational pharmaceutical company with a Gaithersburg campus, announced Monday that its COVID-19 vaccine candidate shows a 70% average efficacy rate. The vaccine candidate AZD1222 was administered in two ways. It showed 90% efficacy when it was given as a half dose and followed by a full dose at least one month later, according […]
Pascal Soriot
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia